CAS 27469-60-9|1-(bis(4-fluorophenyl)methyl)piperazine
| Common Name | 1-(bis(4-fluorophenyl)methyl)piperazine | ||
|---|---|---|---|
| CAS Number | 27469-60-9 | Molecular Weight | 288.335 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 367.9±37.0 °C at 760 mmHg |
| Molecular Formula | C17H18F2N2 | Melting Point | 88-92 °C(lit.) |
| MSDS | / | Flash Point | 176.3±26.5 °C |
| Symbol | GHS06 | Signal Word | Danger |
Names
| Name | 1-[bis(4-fluorophenyl)methyl]piperazine |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 367.9±37.0 °C at 760 mmHg |
| Melting Point | 88-92 °C(lit.) |
| Molecular Formula | C17H18F2N2 |
| Molecular Weight | 288.335 |
| Flash Point | 176.3±26.5 °C |
| Exact Mass | 288.143799 |
| PSA | 15.27000 |
| LogP | 2.95 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.560 |
| InChIKey | TTXIFFYPVGWLSE-UHFFFAOYSA-N |
| SMILES | Fc1ccc(C(c2ccc(F)cc2)N2CCNCC2)cc1 |
| Water Solubility | 0.34 g/L (20 ºC) |
Safety Information
| Symbol | GHS06 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H315-H319-H335 |
| Precautionary Statements | P261-P301 + P310-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T:Toxic |
| Risk Phrases | R25;R36/37/38 |
| Safety Phrases | S26-S45-S36/37/39 |
| RIDADR | UN 2811 6.1/PG 3 |
| WGK Germany | 3 |
| Packaging Group | I; II; III |
| Hazard Class | 6.1 |
Articles2
More Articles| Oxidative metabolism of flunarizine in rat liver microsomes. Res. Commun. Chem. Pathol. Pharmacol. 78(1) , 85-95, (1992) The oxidative metabolism of flunarizine [1-[bis(4-fluorophenyl)-methyl]-4-(3-phenyl-2-propenyl)piperazine, FZ] to 1-[bis-(4-fluorophenyl)methyl]piperazine (M-1), 1-[bis(4-fluorophenyl)methyl]-4-[3-(4'... | |
| Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite. Arch. Toxicol. 69(6) , 391-6, (1995) Toxic effects of a detriazinyl metabolite of almitrine (DTMA) were evaluated in rats and on cultured rat macrophages. In rats daily treated with DTMA for 16 weeks, spastic gaits with heel-lifting appe... |
Synonyms
| N-[bis(4-fluorophenyl)methyl]piperazine |
| 1-(4,4'-Difluorodiphenylmethyl)piperazine |
| 4,4'-Difluorobenzhydrylpiperazine |
| 1-[Bis-(4-fluorophenyl)methyl]piperazine |
| 1-[(4',4''-difluorodiphenyl)methyl]piperazine |
| MFCD00038660 |
| 1 [bis(4-Fluorophenyl)methyl]-piperazine |
| 1-[Bis(4-fluorophenyl)methyl]piperazine |
| 1-(4,4'-Difluorobenzhydryl)piperazine |
| 1-(bis(4-fluorophenyl)methyl)piperazine |
| [bis(4-fluorophenyl)methyl]piperazine |
| 1-Bis(4-fluorophenyl)methyl piperazine |
| Piperazine, 1-[bis(4-fluorophenyl)methyl]- |
| 1-[bis-(p-fluorophenyl)methyl]piperazine |
| EINECS 248-476-0 |
